Literature DB >> 227552

Antibodies to bovine leukemia virus in a leukosis dairy herd and suggestions for control of the infection.

G A Ferdinand, A Langston, R Ruppanner, S Drlica, G H Theilen, D E Behymer.   

Abstract

A closed herd of 765 Holstein-Friesian dairy cattle with a history of multiple cases of leukosis was tested for antibodies to bovine leukemia virus by the bovine leukemia-glycoprotein immunodiffusion test. A total of 355 animals (46.4%) were antibody positive. Prevalence was 60% in the 373 milking cows and 100% in the breeding bulls. Antibodies were present in 59% of newborn calves. Prevalence of antibodies was higher in older animals and cows in second lactation had a higher prevalence than cows in first lactation (72% vs 43%). Proposed control measures in this herd aim at preventing infection of calves, heifers and lactating cows by: 1) separating them into groups negative and positive for bovine leukemia virus antibodies, 2) not allowing calves to receive colstrum or milk from infected cows and 3) by using seronegative bulls for natural breeding tested at three month intervals. Calves should be tested after six months of age. Before this time calves of positive mothers should be treated as being positive.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 227552      PMCID: PMC1319913     

Source DB:  PubMed          Journal:  Can J Comp Med        ISSN: 0008-4050


  16 in total

1.  EPIZOOTIOLOGY OF LYMPHOSARCOMA IN CALIFORNIA CATTLE.

Authors:  G H THEILEN; R D APPLEMAN; H G WIXOM
Journal:  Ann N Y Acad Sci       Date:  1963-11-04       Impact factor: 5.691

2.  PEDIGREE STUDIES IN BOVINE LYMPHOSARCOMA.

Authors:  J E CROSHAW; D A ABT; R R MARSHAK; W C HARE; J SWITZER; J IPSEN; R M DUTCHER
Journal:  Ann N Y Acad Sci       Date:  1963-11-04       Impact factor: 5.691

3.  Comparison of production variables of bovine leukemia virus antibody-negative and antibody-positive cows in two California dairy herds.

Authors:  A Langston; G A Ferdinand; R Ruppanner; G H Theilen; S Drlica; D Behymer
Journal:  Am J Vet Res       Date:  1978-07       Impact factor: 1.156

4.  Precipitating antibody to an internal antigen of the C-type virus associated with bovine lymphosarcoma.

Authors:  J M Miller; C Olson
Journal:  J Natl Cancer Inst       Date:  1972-11       Impact factor: 13.506

Review 5.  Bovine lymphosarcoma (leukemia)-a synopsis.

Authors:  C Olson
Journal:  J Am Vet Med Assoc       Date:  1974-10-01       Impact factor: 1.936

6.  Epidemiologic and pedigree study of the occurrence of lymphosarcoma from 1953 to 1971 in a closed herd of Jersey cows.

Authors:  R H Cypess; J H Waller; C K Redmond; R J Tashjian; A I Hurvitz
Journal:  Am J Epidemiol       Date:  1974-01       Impact factor: 4.897

7.  Influence of sire on BVL infection in progeny.

Authors:  L E Baumgartener; J Crowley; S Entine; C Olson; G Hugoson; H J Hansen; W H Dreher
Journal:  Zentralbl Veterinarmed B       Date:  1978

8.  Fetal infection with bovine leukemia virus in sheep.

Authors:  M Onuma; L E Baumgartener; C Olson; L D Pearson
Journal:  Cancer Res       Date:  1977-11       Impact factor: 12.701

9.  Evidence of bovine C-type (leukemia) virus in dairy cattle.

Authors:  C Olson; H E Hoss; J M Miller; L E Baumgartener
Journal:  J Am Vet Med Assoc       Date:  1973-08-15       Impact factor: 1.936

10.  Effect of pasteurization and heat treatment on bovine leukemia virus.

Authors:  L Baumgartener; C Olson; M Onuma
Journal:  J Am Vet Med Assoc       Date:  1976-12-01       Impact factor: 1.936

View more
  2 in total

1.  Control of bovine leukosis virus in a dairy herd by a change in dehorning.

Authors:  R F DiGiacomo; S G Hopkins; R L Darlington; J F Evermann
Journal:  Can J Vet Res       Date:  1987-10       Impact factor: 1.310

2.  Using a herd profile to determine age-specific prevalence of bovine leukemia virus in michigan dairy herds.

Authors:  Ronald J Erskine; Paul C Bartlett; Todd M Byrem; Chelsea L Render; Catherine Febvay; Jessica T Houseman
Journal:  Vet Med Int       Date:  2012-03-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.